Introduction to discussion papers on draft FDA guidance on adaptive designs.
AMAG Pharmaceuticals, Inc., Lexington, Massachusetts, USA. mchang@amagpharma.com
Mark
M
Chang
D002986:Clinical Trials as Topic / Q000379:methods* / Q000706:statistics & numerical data; D003627:Data Interpretation, Statistical; D017277:Drug Approval / Q000379:methods*; D017408:Guidelines as Topic; D006801:Humans; D015233:Models, Statistical; D015203:Reproducibility of Results; D012107:Research Design; D016896:Treatment Outcome; D014481:United States